Health
NIH to conduct large trial for COVID-19 polyclonal antibody therapies – News-Medical.Net
The National Institutes of Health (NIH) in the USA are to conduct a large-scale clinical trial to evaluate a new fully-human polyclonal antibody therapy targeted…

The National Institutes of Health (NIH) in the USA are to conduct a large-scale clinical trial to evaluate a new fully-human polyclonal antibody therapy targeted at severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative pathogen of coronavirus disease 2019 (COVID-19).
Non-hospitalized people with mild or moderate cases of COVID-19 are to be enrolled at sites around the world, for a test trial called ACTIV-2, which is a part of NIH’s Accelerating COVID-19 Therapeutic Interventions…
-
General22 hours ago
Australian celebrity chef Peter Russell-Clarke dies aged 89
-
Noosa News21 hours ago
Woman airlifted to Brisbane hospital after big cat mauling at south-east Queensland zoo near Toowoomba
-
General24 hours ago
Back-to-back rate cuts tipped when Reserve Bank meets
-
General23 hours ago
Lithium mine closure shines light on Ravensthorpe community’s resilience